Robert Burns
Stock Analyst at HC Wainwright & Co.
(2.23)
# 2,852
Out of 5,049 analysts
471
Total ratings
40.09%
Success rate
-2.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACET Adicet Bio | Maintains: Buy | $4 → $9 | $0.68 | +1,229.79% | 2 | Nov 7, 2025 | |
| RVMD Revolution Medicines | Maintains: Buy | $72 → $73 | $61.38 | +18.93% | 21 | Nov 6, 2025 | |
| EXEL Exelixis | Maintains: Buy | $46 → $49 | $40.80 | +20.10% | 11 | Nov 5, 2025 | |
| CRBU Caribou Biosciences | Maintains: Buy | $3 → $9 | $2.14 | +320.56% | 15 | Nov 5, 2025 | |
| COGT Cogent Biosciences | Reiterates: Buy | $21 | $14.72 | +42.66% | 14 | Nov 4, 2025 | |
| MGNX MacroGenics | Reiterates: Neutral | $2 | $1.36 | +47.06% | 22 | Nov 3, 2025 | |
| FATE Fate Therapeutics | Upgrades: Buy | $5 | $1.04 | +380.77% | 8 | Oct 31, 2025 | |
| RPTX Repare Therapeutics | Maintains: Buy | $5 → $3 | $1.69 | +77.51% | 19 | Oct 27, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $33 → $28 | $12.52 | +123.64% | 19 | Oct 27, 2025 | |
| REPL Replimune Group | Upgrades: Buy | $12 | $8.50 | +41.18% | 20 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7 | $4.78 | +46.44% | 1 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $4.16 | +68.27% | 22 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $13 → $26 | $17.90 | +45.25% | 22 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 | $5.22 | +187.36% | 3 | Oct 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.23 | +348.43% | 5 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.35 | +270.37% | 17 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $5.02 | +99.20% | 15 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $27 | $12.25 | +120.41% | 1 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $24 | $7.35 | +226.53% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $3.03 | +164.03% | 9 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $20 | $9.88 | +102.43% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $136 | $103.35 | +31.59% | 45 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $3.16 | +975.95% | 4 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $14 | $6.53 | +114.40% | 22 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $40 | $14.57 | +174.54% | 5 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $19 | $12.55 | +51.39% | 25 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $42 | $18.39 | +128.38% | 11 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $3.98 | +151.26% | 14 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $10 | $2.25 | +344.44% | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $9.02 | +44.12% | 8 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $48 | $18.30 | +162.30% | 5 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.45 | +389.80% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $8.01 | +62.30% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.25 | +300.00% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.05 | +661.90% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $11.82 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $13.32 | +1,401.50% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,320 → $240 | $1.66 | +14,357.83% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.55 | +27,000.27% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $4.19 | +162.53% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50,000 → $45,000 | $3.64 | +1,236,163.74% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $4.68 | +434.19% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $1.36 | +855.88% | 1 | Jan 7, 2021 |
Adicet Bio
Nov 7, 2025
Maintains: Buy
Price Target: $4 → $9
Current: $0.68
Upside: +1,229.79%
Revolution Medicines
Nov 6, 2025
Maintains: Buy
Price Target: $72 → $73
Current: $61.38
Upside: +18.93%
Exelixis
Nov 5, 2025
Maintains: Buy
Price Target: $46 → $49
Current: $40.80
Upside: +20.10%
Caribou Biosciences
Nov 5, 2025
Maintains: Buy
Price Target: $3 → $9
Current: $2.14
Upside: +320.56%
Cogent Biosciences
Nov 4, 2025
Reiterates: Buy
Price Target: $21
Current: $14.72
Upside: +42.66%
MacroGenics
Nov 3, 2025
Reiterates: Neutral
Price Target: $2
Current: $1.36
Upside: +47.06%
Fate Therapeutics
Oct 31, 2025
Upgrades: Buy
Price Target: $5
Current: $1.04
Upside: +380.77%
Repare Therapeutics
Oct 27, 2025
Maintains: Buy
Price Target: $5 → $3
Current: $1.69
Upside: +77.51%
Nurix Therapeutics
Oct 27, 2025
Maintains: Buy
Price Target: $33 → $28
Current: $12.52
Upside: +123.64%
Replimune Group
Oct 27, 2025
Upgrades: Buy
Price Target: $12
Current: $8.50
Upside: +41.18%
Oct 20, 2025
Assumes: Buy
Price Target: $7
Current: $4.78
Upside: +46.44%
Oct 16, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $4.16
Upside: +68.27%
Oct 14, 2025
Upgrades: Buy
Price Target: $13 → $26
Current: $17.90
Upside: +45.25%
Oct 13, 2025
Upgrades: Buy
Price Target: $15
Current: $5.22
Upside: +187.36%
Oct 3, 2025
Reiterates: Buy
Price Target: $10
Current: $2.23
Upside: +348.43%
Sep 23, 2025
Reiterates: Buy
Price Target: $5
Current: $1.35
Upside: +270.37%
Sep 19, 2025
Reiterates: Buy
Price Target: $10
Current: $5.02
Upside: +99.20%
Sep 15, 2025
Initiates: Buy
Price Target: $27
Current: $12.25
Upside: +120.41%
Sep 12, 2025
Reiterates: Buy
Price Target: $24
Current: $7.35
Upside: +226.53%
Sep 12, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $3.03
Upside: +164.03%
Sep 10, 2025
Maintains: Buy
Price Target: $23 → $20
Current: $9.88
Upside: +102.43%
Sep 8, 2025
Reiterates: Buy
Price Target: $136
Current: $103.35
Upside: +31.59%
Aug 26, 2025
Reiterates: Buy
Price Target: $34
Current: $3.16
Upside: +975.95%
Aug 26, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $6.53
Upside: +114.40%
Aug 22, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $14.57
Upside: +174.54%
Aug 14, 2025
Maintains: Buy
Price Target: $22 → $19
Current: $12.55
Upside: +51.39%
Aug 12, 2025
Maintains: Buy
Price Target: $40 → $42
Current: $18.39
Upside: +128.38%
Aug 11, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.98
Upside: +151.26%
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $2.25
Upside: +344.44%
Jul 17, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $9.02
Upside: +44.12%
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $18.30
Upside: +162.30%
May 16, 2025
Reiterates: Buy
Price Target: $12
Current: $2.45
Upside: +389.80%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $8.01
Upside: +62.30%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.25
Upside: +300.00%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.05
Upside: +661.90%
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $11.82
Upside: -
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $13.32
Upside: +1,401.50%
Mar 21, 2024
Maintains: Buy
Price Target: $1,320 → $240
Current: $1.66
Upside: +14,357.83%
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $0.55
Upside: +27,000.27%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $4.19
Upside: +162.53%
Nov 24, 2021
Maintains: Buy
Price Target: $50,000 → $45,000
Current: $3.64
Upside: +1,236,163.74%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $4.68
Upside: +434.19%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $1.36
Upside: +855.88%